Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Cerebral Infarction
Total 0 results
Nothing found
Sponsors and Collaborators
Ministry of Public Health, Cameroon
Defence Services Medical Academy (DSMA), Myanmar
NERv Technology Inc
Nutrabolt
BioNova Pharmaceuticals (Shanghai) LTD.
Pia Jaeger, MD, PhD
Huisartspraktijk Handellaan
Health Information Technology Solutions (HITS) LLC
The Affiliated Hospital of Xuzhou Medical University
Salena Killion
Vivid Pharma Inc.
Cogniciti
Université de Genève (UNIGE)
Zhongda Hospital, Medical School, Southeast University
Smart Meter Corporation
Hungarian Dental Association
HBSA
Shanghai GeneChem Co., Ltd.
Impulse Dynamics, Inc.
UNITI Consortium
View Full List
Medical Conditions
Old Age (Focus; Not a Recognized Condition)
Infection, Bacterial
Alzheimer Disease Focal
SMA - Spinal Muscular Atrophy
Research Mentoring Skills
Cardiovascular Primary Prevention
Radiofrequency Ablation Treatment
Failed Induction
Vertebral Compression Fractures in Osteoporotic Patients
Immediate Implant Placement
Cerebral Arterial Disease
Pain, Breakthrough
Eye Disease, Hereditary
PPA Syndrome
Endoleaks
PET-CT Specimen Imager
Advanced Bladder Carcinoma
Biomarkers, Pharmacological
Premature Rupture of Membranes Prolonged
VEXAS Syndrome
View Full List
Drug Interventions
80% oxygen
CJ-12420 200mg + Clarithromycin 500mg
Oxymorphone hydrochloride (HCl)
Lacosamide
HPN328
0.75% Ropivacaine
Rosuvastatin
Microneedling with topical glycolic acid 35%.
INT-747
Acetylsalicylic acid
20 mg/kg IV FL-301
5 FU continuous
Phase B: Triplixam / Elestar HCT
OXP005
18F-FDG
TQB2450
CNTO 6785 50 mg
Cefadroxil until drain removal
Olopatadine hydrochloride 0.2%
Durvalumab + chemotherapy treatment
View Full List
CROs by country
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Gambia
Contract Research Organizations in Ghana
Contract Research Organizations in Greece
Contract Research Organizations in Liberia
Contract Research Organizations in Lithuania
Contract Research Organizations in Mexico
Contract Research Organizations in Mongolia
Contract Research Organizations in Paraguay
Contract Research Organizations in Thailand
Contract Research Organizations in United Kingdom
Contract Research Organizations in Vietnam
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Bahamas
SGS
All CROs in Bahamas
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe